Rajat Desikan
GlaxoSmithKline (United Kingdom)(GB)Age UK(GB)Simulation Technologies (United States)(US)Kalamazoo College(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Lipid Membrane Structure and Behavior, Bacteriophages and microbial interactions, Nanopore and Nanochannel Transport Studies, COVID-19 Clinical Research Studies
Most-Cited Works
- → Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection(2020)147 cited
- → Modeling how antibody responses may determine the efficacy of COVID-19 vaccines(2022)60 cited
- → Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response(2019)45 cited
- → Capturing the Membrane-Triggered Conformational Transition of an α-Helical Pore-Forming Toxin(2016)37 cited
- → Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost(2021)34 cited
- → Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection(2020)30 cited